SVB Wealth LLC Buys New Position in The Clorox Company (NYSE:CLX)

SVB Wealth LLC bought a new position in shares of The Clorox Company (NYSE:CLX - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 1,840 shares of the company's stock, valued at approximately $299,000.

Several other hedge funds and other institutional investors also recently bought and sold shares of CLX. Brooklyn Investment Group increased its position in shares of Clorox by 163.8% during the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company's stock valued at $25,000 after purchasing an additional 95 shares during the period. Prospera Private Wealth LLC acquired a new position in Clorox in the third quarter valued at about $27,000. Continuum Advisory LLC boosted its holdings in shares of Clorox by 300.0% in the 3rd quarter. Continuum Advisory LLC now owns 184 shares of the company's stock worth $30,000 after acquiring an additional 138 shares in the last quarter. Asset Planning Inc bought a new position in Clorox in the 4th quarter valued at $32,000. Finally, BankPlus Trust Department acquired a new position in Clorox in the fourth quarter worth $40,000. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Clorox Stock Down 0.7 %

CLX stock opened at $149.76 on Thursday. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60. The business's fifty day moving average price is $156.21 and its two-hundred day moving average price is $160.41. The Clorox Company has a fifty-two week low of $127.60 and a fifty-two week high of $171.37. The stock has a market capitalization of $18.45 billion, a price-to-earnings ratio of 40.92, a PEG ratio of 2.62 and a beta of 0.42.

Clorox (NYSE:CLX - Get Free Report) last announced its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same quarter last year, the firm posted $2.16 EPS. On average, equities analysts anticipate that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Wednesday, April 23rd will be given a dividend of $1.22 per share. The ex-dividend date of this dividend is Wednesday, April 23rd. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.26%. Clorox's payout ratio is 133.33%.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on the stock. JPMorgan Chase & Co. boosted their target price on shares of Clorox from $171.00 to $173.00 and gave the stock a "neutral" rating in a research note on Tuesday, February 4th. TD Cowen upgraded shares of Clorox from a "sell" rating to a "hold" rating and upped their target price for the company from $155.00 to $170.00 in a research report on Wednesday, November 6th. Barclays lifted their price objective on shares of Clorox from $130.00 to $140.00 and gave the stock an "underweight" rating in a research note on Wednesday, February 5th. StockNews.com downgraded Clorox from a "buy" rating to a "hold" rating in a research note on Sunday, January 5th. Finally, Wells Fargo & Company lifted their price target on shares of Clorox from $157.00 to $161.00 and gave the company an "equal weight" rating in a research note on Tuesday, February 4th. Three analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has given a buy rating to the company's stock. According to MarketBeat, Clorox has an average rating of "Hold" and a consensus target price of $159.62.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.